Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2023 | Unmet needs in Burkitt lymphoma: diagnosis and treatment

Sam Mbulaiteye • 16 Jun 2023
ICML 2023
Burkitt Lymphoma Lymphoma Non-Hodgkin Lymphoma

Sam Mbulaiteye, MBChB, M.Phil., M.Med., National Institutes of Health, Bethesda, MD, gives an overview of unmet needs in the diagnosis and treatment of Burkitt lymphoma, and further highlights the value of novel targeted therapies and technologies. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Sam Mbulaiteye

0:53
The International Burkitt Lymphoma Network: a valuable opportunity for collaboration
Sam Mbulaiteye • 16 Jun 2023
2:07
LBA: genome-wide association study of childhood Burkitt lymphoma in East Africa
Sam Mbulaiteye • 16 Jun 2023

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals